Abdominal Abscess — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for abdominal abscess. 23 active patents protecting 3 drugs from 3+ originators. First major cliff: 2031. Daily refresh.

3
Approved drugs
23
Active US patents
55/100
Avg vulnerability
—
Annual revenue covered

Originators in Abdominal Abscess

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Pfizer 10 patents Baxter 9 patents Fresenius Kabi 4 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating abdominal abscess. Each bar = one year. Y-axis scaled to peak year (7 patents).

4
28
1
29
1
30
7
31
4
32
1
33
1
38
4
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Merrem
Meropenem
 Pfizer 10 57 — 2031-08-08
Metro I.V. In Plastic Container
METRONIDAZOLE
 Baxter 9 58 — 2028-02-02
Tygacil
TIGECYCLINE
 Fresenius Kabi 4 49 — 2028-10-24

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8658678 Metro I.V. In Plastic Container method of use 75 2028-06-27
12478606 Merrem method of use 75 2038-01-08
12257236 Metro I.V. In Plastic Container method of use 75 2039-01-16
12533342 Merrem method of use 75 2039-05-20
11376237 Merrem method of use 70 2039-04-06
10561675 Merrem method of use 68 2031-08-08
11007206 Merrem method of use 68 2031-08-08
9694025 Merrem method of use 68 2031-08-08
10183034 Merrem method of use 68 2031-08-08
9198858 Metro I.V. In Plastic Container method of use 62 2032-06-28

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8680136 Merrem composition of matter 10 2031-08-29
12171772 Merrem composition of matter 23 2031-08-08
9855335 Tygacil formulation 42 2033-04-07
10596155 Metro I.V. In Plastic Container formulation 42 2032-06-28
10238634 Metro I.V. In Plastic Container formulation 42 2032-06-28
10172874 Merrem formulation 48 2031-08-08
11541035 Metro I.V. In Plastic Container formulation 50 2039-10-04
8372995 Tygacil formulation 53 2030-10-08
8975242 Tygacil formulation 55 2028-10-24
7893097 Metro I.V. In Plastic Container formulation 55 2028-02-19

Related